
No cow needed: Oat and soy can be called milk, FDA proposes
Read GFI's response to FDA's recent draft guidance on plant-based milk labeling.
Read GFI's response to FDA's recent draft guidance on plant-based milk labeling.
GFI's Madeline Cohen discusses FDA's draft guidance on plant-based milk labeling, and how it can be detrimental to U.S. climate goals.
Join the NY Lawyer Chapter of the American Constitution Society for a conversation with GFI Senior Regulatory Attorney, Madeline Cohen, as they lead a discussion on legal, regulatory, and policy issues affecting alternatives to traditional meat products.
Applications to join the Alt Protein Project are now live! Attend our information sessions for students interested in bringing the alternative protein movement to their university.
Applications to join the Alt Protein Project are now live! Attend our information sessions for students interested in bringing the alternative protein movement to their university.
Join the Future of Protein Production Summit to connect virtually with alternative protein industry leaders.
GFI's Sheila Voss reflects on the importance of food sustainability and alternative proteins in global policy conversations.
Inspiring organizations and individuals around the world are reducing emissions, saving lands and waters, protecting public health, and increasing food security. Yet threats still mount. Alt proteins are essential for winning on every front.
MEVO is a leaders summit that exclusively brings in-person up to 250 decision makers from prominent to small-sized manufacturers, commercial producers, investors, cutting-edge technology providers, intellectuals, brands and future food vanguards who want to increase their knowledge and footprint in this lucrative growth market.
The alternative protein industry today shows signs of resilience despite challenges across the macroeconomic landscape, geopolitical dynamics, and talent, funding, and infrastructure constraints. GFI experts predict the industry trends that will drive the next wave of developments toward mass adoption.